Journal SAM (November 2012): From the Angio Suite to the g-Camera: Vascular Mapping and 99mTc-MAA Hepatic Perfusion Imaging Before Liver Radioembolization—A Comprehensive Pictorial Review

MOC Part II SAM Modules

Journal SAM: From the Angio Suite to the y-Camera: Vascular Mapping and 99mTc-MAA Perfusion Imaging Before Liver Radioemolization - A Comprehensive Pictorial Review

Member Fee:  Free
Non-Member Fee:  $90.00


Release Date: 11/1/2012
Expiration Date: 11/30/2015


Credit Info.

ABNM SAM Credit
The American Board of Nuclear Medicine has reviewed and approved this Journal SAM activity submitted by the SNMMI. This activity fulfills the requirements of the ABNM Maintenance of Certification program for self-assessment.   2.0 SAMs have been awarded for this activity.


AMA-PRA (Physician)
The Society for Nuclear Medicine and Medical Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

SNMMI designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity. 


Objectives

Upon successful completion of this activity, participants should be able to describe:

1. The rationale and the aims of conjoint endovascular mapping and 99mTc-macroaggregated albumin (99mTc-MAA) hepatic perfusion imaging before liver radioembolization.
2. How to integrate the information gathered during the angiographic procedure with the SPECT/CT hepatic perfusion study to generate an interpretation relevant to clinical management.
3. Various sites of 99mTc-MAA activity outside the liver parenchyma and their potential origin in order to avoid nontargeted radioembolization.
4. Pitfalls in 99mTc-MAA hepatic perfusion imaging and how to avoid them.


Target Audience

Journal SAMs are designed for all nuclear medicine specialists and other physicians, pharmacists and technologists who practice diagnostic and/or therapeutic nuclear medicine.


 Author Disclosure(s)

Livnat Uliel, MD; Henry D. Royal, MD; Darryl A. Zuckerman, MD; Akash Sharma, MD; and Nael E. Saad, MD

In accordance with ACCME Revised Standards for Commercial Support and SNMMI Conflict-of-Interest Policy, the authors have indicated no relevant relationships that could be perceived as a real or apparent conflict of interest. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity.


Contact Information

Please contact Lisa Lefebvre, Associate Director of Education, MOC at 
llefebvre@snmmi.org or 703-652-6783 with any questions or comments.